Ovid Therapeutics announced the appointment of Amanda Banks, M.D., as Chief Development Officer. Dr. Banks will oversee Ovid‘s clinical development, medical, and regulatory affairs functions as well as drive corporate development strategy and execution in partnership with the Company’s leadership team.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVID:
- OVID Earnings this Week: How Will it Perform?
- Ovid Therapeutics Announces Leadership Transition and Consulting Deal
- Ovid Therapeutics to Present at Upcoming August Investor Conferences
- Ovid Therapeutics expands scientific advisory board
- Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists